Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.70
-0.74 (-2.43%)
At close: Dec 20, 2024, 4:00 PM
30.00
+0.30 (1.01%)
After-hours: Dec 20, 2024, 7:47 PM EST
Collegium Pharmaceutical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 88.59 | 48.16 | -25 | 71.52 | 26.75 | -22.72 | Upgrade
|
| Depreciation & Amortization | 148.11 | 149.26 | 134.15 | 68.92 | 61.55 | 15.48 | Upgrade
|
| Other Amortization | 6.56 | 8.64 | 8.29 | 3.41 | 8.97 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 4.79 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.22 | -1.24 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 31.81 | 27.14 | 22.87 | 24.26 | 21.91 | 16.53 | Upgrade
|
| Other Operating Activities | -5.28 | 21.07 | -8.15 | -78.02 | 0.06 | 0.31 | Upgrade
|
| Change in Accounts Receivable | -2.19 | 3.59 | -21.78 | -22.52 | -10.37 | 4.99 | Upgrade
|
| Change in Inventory | 13.25 | 14.17 | 48.27 | -2.3 | -8.27 | -1.83 | Upgrade
|
| Change in Accounts Payable | -7.13 | 5.06 | -0.71 | -5.83 | 3.77 | -5.9 | Upgrade
|
| Change in Other Net Operating Assets | -77.81 | -1.09 | -38.5 | 44.13 | -10.43 | 20.92 | Upgrade
|
| Operating Cash Flow | 193.67 | 274.75 | 124.23 | 103.56 | 93.94 | 27.78 | Upgrade
|
| Operating Cash Flow Growth | -27.66% | 121.16% | 19.96% | 10.24% | 238.13% | -83.60% | Upgrade
|
| Capital Expenditures | -1.25 | -0.46 | -1.62 | -1.94 | -5.55 | -6.44 | Upgrade
|
| Cash Acquisitions | -267.54 | - | -572.07 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -368.23 | - | Upgrade
|
| Investment in Securities | -32.31 | -70.35 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -301.09 | -70.81 | -573.69 | -1.94 | -373.77 | -6.44 | Upgrade
|
| Long-Term Debt Issued | - | 241.5 | 517.68 | - | 338.32 | - | Upgrade
|
| Total Debt Issued | 319.46 | 241.5 | 517.68 | - | 338.32 | - | Upgrade
|
| Long-Term Debt Repaid | - | -301.14 | -75 | -50 | -49 | - | Upgrade
|
| Net Debt Issued (Repaid) | -15.89 | -59.64 | 442.68 | -50 | 289.32 | - | Upgrade
|
| Issuance of Common Stock | 14.14 | 9.1 | 12.15 | 12.71 | 7.34 | 2.86 | Upgrade
|
| Repurchase of Common Stock | -79.12 | -83.36 | -18.11 | -52.01 | -2.26 | -0.82 | Upgrade
|
| Other Financing Activities | -6.28 | -6.28 | - | - | -7.93 | - | Upgrade
|
| Financing Cash Flow | -87.15 | -140.18 | 436.72 | -89.3 | 286.47 | 2.04 | Upgrade
|
| Net Cash Flow | -194.57 | 63.76 | -12.74 | 12.31 | 6.64 | 23.39 | Upgrade
|
| Free Cash Flow | 192.43 | 274.29 | 122.61 | 101.61 | 88.4 | 21.35 | Upgrade
|
| Free Cash Flow Growth | -27.79% | 123.71% | 20.66% | 14.95% | 314.13% | -86.98% | Upgrade
|
| Free Cash Flow Margin | 32.11% | 48.40% | 26.43% | 36.70% | 28.51% | 7.19% | Upgrade
|
| Free Cash Flow Per Share | 4.21 | 6.56 | 3.62 | 2.48 | 2.51 | 0.64 | Upgrade
|
| Cash Interest Paid | 62.79 | 73.26 | 52.53 | 17.61 | 18.97 | 0.71 | Upgrade
|
| Cash Income Tax Paid | 58.38 | 24.21 | 10.4 | 3.01 | 0.48 | - | Upgrade
|
| Levered Free Cash Flow | 299.09 | 274.32 | 114.39 | 109.21 | -288.37 | 25.13 | Upgrade
|
| Unlevered Free Cash Flow | 336.66 | 317.77 | 145.62 | 118.93 | -279.29 | 25.7 | Upgrade
|
| Change in Net Working Capital | -21.92 | -22.73 | 77.47 | -13.83 | 24.12 | -14.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.